Skip to the page

Data / Form D filings / Verismo Therapeutics, Inc.

Verismo Therapeutics, Inc.: Form D filings

Verismo Therapeutics, Inc., a health care company in Philadelphia, PA, filed 3 Form D notices with the SEC between 2021 and 2026. The latest, on May 20, 2026, reports $28 million sold of a $28 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3675 Market Street, Suite 200, Philadelphia, PA, 19104
Phone
(609) 790-5188
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1855431

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 20, 2026New notice$28,000,000$28,000,0001Apr 21, 2026sec.gov
Jul 14, 2023New noticeIndefinite$19,150,0127Jul 7, 2023sec.gov
Apr 27, 2021New notice$16,000,000$16,000,0003Apr 26, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Gene KimExecutive Officer
Bryan B. KimExecutive Officer, Director
Yang Gon JinDirector
Jong Sun YoonDirector
Dong Gun KimDirector

Other health care companies in Pennsylvania that filed recently

Every Form D from the week of May 18, 2026 · All recent filings in Pennsylvania · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Verismo Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.